Nicholas Poe Associate Litigation Nicholas represents technology and life sciences companies in a broad range of securities litigation matters.
Publications Interoperable or Infringing: Ninth Circuit Requires “Something More” for Rightsholders to Claim Derivative Works December 20, 2024
Experience Fenwick Secures Settlement for Lashify as Chinese Beauty Company Agrees to Halt Imports in Patent Dispute November 11, 2024
